CAUTION ADVISED USING COMBINATION KETOCONAZOLE AND PD-1 INHIBITORS

OBJECTIVE: Immune checkpoint inhibitors are approved to treat multiple cancers. We report life-threatening hepatic failure in 2 consecutive patients with Cushing syndrome that were treated with ketoconazole (KTZ) in combination with 2 different programmed cell death protein 1 (PD-1) inhibitors, Nivo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:AACE Clin Case Rep
Hlavní autoři: Yang, Yingying, Hecht, Joel R., Liu, Sandy Ting, Cohen, Melissa J., Hart, Steven D., Wang, Hanlin L., Heaney, Anthony P.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Association of Clinical Endocrinologists 2020
Témata:
Case Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7511096/
https://ncbi.nlm.nih.gov/pubmed/32984529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2020-0100
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky